Fostering Nurse Engagement in Psychedelic-Assisted Therapies for Patients with Serious Illness
William E Rosa, Caroline Dorsen, A. Penn
Journal of Palliative Medicine September 22, 2020 DOI: 10.1089/jpm.2020.0241 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Key points | Argues that nurses and nursing are noticeably absent from the emerging literature on psychedelic-assisted therapies, including in palliative care, and calls on colleagues in medicine to help rectify this omission, which the authors contend is critical to the future of these therapies and patient outcomes. |
Abstract
We applaud the findings of Beaussant and colleagues 1 in defining the research priorities for psychedelic-assisted therapies in palliative care. The innovative conceptual framework posed for integrating these therapies into extant care delivery models promotes the strategic use of psychedelic-assisted interventions capable of reaching those patients most in need. A recent scoping review of psychedelic-assisted therapies with a focus on mental health, addictions, and palliative care highlights that nursing involvement in the relevant literature is noticeably absent. 2 The invisibility of nurses and nursing in the emergent field of psychedelic-assisted therapy is an omission we call upon our colleagues in medicine to help us rectify. Our recommendations are critical to both the future of psychedelic-assisted therapies and associated patient outcomes.